Decoy Therapeutics shares are surging Monday after a $21 million private placement financing with a healthcare investor at $5.91 per share.
Decoy Therapeutics Inc.
(NASDAQ:DCOY) shares are trading higher.
The company announced a $21 million private placement financing with a healthcare investor at $5.91 per share.
The Financing The private placement consists of four components.
The upfront portion provides approximately $3.5 million in gross proceeds from the sale of common stock at $5.91 per share.
Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Not for distribution to United States wire services or for dissemination in the United States VANCOUVER, BC / ACCESS Newswire /…
Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering
Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the…
Definium Therapeutics (DFTX) stock hits $38.24 after positive clinical data, but an 84.57 RSI signals the shares are currently…
Core AI Holdings (CHAI) stock plunges 31% premarket after a $5.4M capital raise sparks dilution fears. Get the full market…
Onco-Innovations Announces Term Sheet for Notional CAD$5 Million Performance-Based Funding Arrangement and Amendments to Previously Announced Financing
Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
